Literature DB >> 35075603

LncRNA NRON negatively regulates cisplatin-induced cell apoptosis via downregulating miR-31 in esophageal squamous cell carcinomas.

Bo Liu1, Xu Li2, Jinbao Xie1, Zhi Feng1, Nanlong Lin1, Minjie Yu1.   

Abstract

LncRNA non-coding repressor of NFAT (NRON) can promote bladder cancer and suppress liver cancer, while its role in esophageal squamous cell carcinoma (ESCC) is unknown. We analyzed its involvement in ESCC. NRON and miR-31 expression in plasma before and after cisplatin treatment was detected using RT-qPCR. The correlation between NRON and miR-31 was analyzed by linear regression. Expression of NRON and miR-31 in ESCC cells was also analyzed using RT-qPCR. Overexpression of NRON and miR-31 was achieved in ESCC cells to explore their interaction. Cell apoptosis induced by cisplatin was studied using cell apoptosis assay. NRON was highly expressed in ESCC and further upregulated after cisplatin treatment. MiR-31 was downregulated in ESCC and inversely correlated with NRON. In ESCC cells, NRON overexpression decreased miR-31 expression, while miR-31 failed to alter NRON expression. Cisplatin treatment promoted NRON expression and inhibited miR-31 expression. Under cisplatin treatment, cell apoptosis was inhibited after NRON overexpression and increased after miR-31 overexpression. Moreover, NRON inhibited the effect of miR-31 on cell apoptosis. NRON might promote the development of cisplatin resistance via downregulating miR-31 in ESCC.
© 2022. The Society for In Vitro Biology.

Entities:  

Keywords:  Apoptosis; Cisplatin; ESCC; NRON; miR-31

Mesh:

Substances:

Year:  2022        PMID: 35075603     DOI: 10.1007/s11626-021-00638-7

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  11 in total

1.  C-terminal binding protein‑2 mediates cisplatin chemoresistance in esophageal cancer cells via the inhibition of apoptosis.

Authors:  Hui Shi; Yinting Mao; Qianqian Ju; Yingcheng Wu; Wen Bai; Peiwen Wang; Yudong Zhang; Maorong Jiang
Journal:  Int J Oncol       Date:  2018-04-12       Impact factor: 5.650

2.  Esophageal Cancer.

Authors:  Matthew W Short; Kristina G Burgers; Vincent T Fry
Journal:  Am Fam Physician       Date:  2017-01-01       Impact factor: 3.292

Review 3.  Epidemiology of Esophageal Squamous Cell Carcinoma.

Authors:  Christian C Abnet; Melina Arnold; Wen-Qiang Wei
Journal:  Gastroenterology       Date:  2017-08-18       Impact factor: 22.682

Review 4.  Recent Advances From Basic and Clinical Studies of Esophageal Squamous Cell Carcinoma.

Authors:  Shinya Ohashi; Shin'ichi Miyamoto; Osamu Kikuchi; Tomoyuki Goto; Yusuke Amanuma; Manabu Muto
Journal:  Gastroenterology       Date:  2015-09-12       Impact factor: 22.682

5.  Over-expression of miR-31 or loss of KCNMA1 leads to increased cisplatin resistance in ovarian cancer cells.

Authors:  Priya Samuel; Ryan Charles Pink; Daniel Paul Caley; James Michael Stevenson Currie; Susan Ann Brooks; David Raul Francisco Carter
Journal:  Tumour Biol       Date:  2015-09-19

6.  Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.

Authors:  Zhicheng Yao; Zhiyong Xiong; Ruixi Li; Hao Liang; Changchang Jia; Meihai Deng
Journal:  Biomed Pharmacother       Date:  2018-05-15       Impact factor: 6.529

7.  Differential expression of miRNAs in esophageal cancer tissue.

Authors:  Shang-Guo Liu; Xiu-Guang Qin; Bao-Sheng Zhao; Bo Qi; Wen-Jian Yao; Tian-Yun Wang; Han-Chen Li; Xiang-Nan Wu
Journal:  Oncol Lett       Date:  2013-03-12       Impact factor: 2.967

8.  Esophageal cancer statistics in China, 2011: Estimates based on 177 cancer registries.

Authors:  Hongmei Zeng; Rongshou Zheng; Siwei Zhang; Tingting Zuo; Changfa Xia; Xiaonong Zou; Wanqing Chen
Journal:  Thorac Cancer       Date:  2015-12-07       Impact factor: 3.500

Review 9.  Long non-coding RNAs in esophageal cancer: molecular mechanisms, functions, and potential applications.

Authors:  Min Su; Yuhang Xiao; Junliang Ma; Deliang Cao; Yong Zhou; Hui Wang; Qianjin Liao; Wenxiang Wang
Journal:  J Hematol Oncol       Date:  2018-09-17       Impact factor: 17.388

10.  LncRNA NRON promotes the proliferation, metastasis and EMT process in bladder cancer.

Authors:  Tiefu Xiong; Chenchen Huang; Jianfa Li; Shaokang Yu; Fangfang Chen; Zeng Zhang; Chengle Zhuang; Yawen Li; Changshui Zhuang; Xinbo Huang; Jing Ye; Fangting Zhang; Yaoting Gui
Journal:  J Cancer       Date:  2020-01-17       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.